Home Cart Sign in  
Chemical Structure| 22494-42-4 Chemical Structure| 22494-42-4

Structure of Diflunisal
CAS No.: 22494-42-4

Chemical Structure| 22494-42-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Diflunisal is a difluorophenyl derivate of salicylic acid and a nonsteroidal anti-inflammatory drug (NSAID) with antipyretic, analgesic and anti-inflammatory properties. The mechanism of action of diflunisal is as a cyclooxygenase Inhibitor.

Synonyms: MK-647; 5-(2,4-Difluorophenyl)salicylic Acid; Dflunisal

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

DE Stock

US Stock

Asia Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Diflunisal

CAS No. :22494-42-4
Formula : C13H8F2O3
M.W : 250.20
SMILES Code : O=C(C1=CC(C2=CC=C(F)C=C2F)=CC=C1O)O
Synonyms :
MK-647; 5-(2,4-Difluorophenyl)salicylic Acid; Dflunisal
MDL No. :MFCD00057834
InChI Key :HUPFGZXOMWLGNK-UHFFFAOYSA-N
Pubchem ID :3059

Safety of Diflunisal

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335-H351-H361
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

Target
  • COX

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT01676363 HIV Infection PHASE4 TERMINATED 2016-10-12 Immunodeficiency Clinic, St. P... More >>aul's Hospital, Vancouver, British Columbia, Canada Less <<
NCT01432587 Amyloidosis COMPLETED 2025-12-14 Dept of Clinical Medicin, Ptie... More >>? Hospital, Pite?, SE-941 28, Sweden|Dept of clinical medicin, Skellefte? Hospital, Skellefte?, SE-931 86, Sweden|Dept of Clinical Medicine, Ume? University Hospital, Ume?, SE-90185, Sweden Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.00mL

0.80mL

0.40mL

19.98mL

4.00mL

2.00mL

39.97mL

7.99mL

4.00mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2

References

 

Historical Records

Categories